These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2906016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J, Handa K, Arakawa K.
    Clin Ther; 1989; 11(5):580-3. PubMed ID: 2478285
    [Abstract] [Full Text] [Related]

  • 3. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H, Stradner F.
    Wien Med Wochenschr; 1986 Sep 15; 136(17):443-8. PubMed ID: 2879389
    [Abstract] [Full Text] [Related]

  • 4. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989 Sep 15; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec 15; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 7. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan 15; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 8. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 15; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 9. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L, Osa A, Palencia M, Flores A, Sánchez E.
    J Heart Lung Transplant; 1997 Apr 15; 16(4):454-9. PubMed ID: 9154957
    [Abstract] [Full Text] [Related]

  • 10. Serum lipid levels in hypertensive patients during captopril treatment.
    Nishide T, Shirai K, Shinomiya M, Ishikawa Y, Murano S, Morisaki N, Saito Y, Yoshida S, Sasaki N.
    Clin Ther; 1989 Apr 15; 11(6):820-7. PubMed ID: 2692824
    [Abstract] [Full Text] [Related]

  • 11. Serum lipids, blood pressure, body weight, and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin ST 1435.
    Laurikka-Routti M.
    Obstet Gynecol; 1992 Nov 15; 80(5):855-9. PubMed ID: 1407928
    [Abstract] [Full Text] [Related]

  • 12. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR, Johnson B, Vaccarino V, Montanari G, Cremoncini M, Gianfranceschi G, Sirtori M, Dujovne CA.
    Clin Pharmacol Ther; 1989 Jun 15; 45(6):617-26. PubMed ID: 2567218
    [Abstract] [Full Text] [Related]

  • 13. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
    Malminiemi K, Lahtela JT, Huupponen R.
    Int J Clin Pharmacol Ther; 1995 Mar 15; 33(3):156-63. PubMed ID: 7599914
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of hypertension with a new beta blocker-diuretic combination under long-term control].
    Hoffmann H, Hoffmann W.
    Wien Med Wochenschr; 1985 Mar 15; 135(5):127-34. PubMed ID: 2859703
    [Abstract] [Full Text] [Related]

  • 15. Effects of celiprolol on serum lipids in systemic hypertension.
    Herrmann JM, Bischof F, Von Heymann F, Freischuetz G, Burghagen H.
    Am J Cardiol; 1988 Feb 10; 61(5):41C-44C. PubMed ID: 2963524
    [Abstract] [Full Text] [Related]

  • 16. A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.
    Herrmann JM, Mayer EO.
    Am Heart J; 1988 Nov 10; 116(5 Pt 2):1416-21. PubMed ID: 2903652
    [Abstract] [Full Text] [Related]

  • 17. [Celiprolol improves glucose metabolism in essential hypertension].
    Oksa A, Fedelesová V, Spustová V, Dzúrik R.
    Vnitr Lek; 1998 Feb 10; 44(2):63-7. PubMed ID: 9820078
    [Abstract] [Full Text] [Related]

  • 18. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
    Yashiro A, Sugano M, Nakashima Y, Tasaki H, Kuroiwa A.
    Clin Ther; 1987 Feb 10; 10(1):98-106. PubMed ID: 2897239
    [Abstract] [Full Text] [Related]

  • 19. Open assessment of the effect of prazosin on plasma lipids.
    Havard CW, Khokhar AM, Flax JS.
    J Cardiovasc Pharmacol; 1982 Feb 10; 4 Suppl 2():S238-41. PubMed ID: 6177964
    [Abstract] [Full Text] [Related]

  • 20. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.
    Clin Endocrinol (Oxf); 2004 Jul 10; 61(1):113-22. PubMed ID: 15212653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.